Health Care Equipment & Services

Centene names former Lincoln CFO Christopher Neczypor to replace Drew Asher, promising seamless transition and steady growth while reaffirming its 2026 financial outlook.

Siemens Healthineers drives shareholder returns through share‑buybacks while expanding high‑margin diagnostic partnerships, boosting EPS growth and value‑based reimbursement.

UnitedHealth Group’s stock slides amid U.S.-Iran tensions, rising oil, and a high‑profile double‑jeopardy case—how legal and geopolitical risks shape its future.

ResMed (RMD) approaches its dividend ex‑date on Aug. 19, amid a stable yet cautious market backdrop. The company’s focus on connected respiratory tech, AI diagnostics, and R&D positions it to capture growth in telehealth while navigating regulatory …

Alcon’s new hedge‑fund spotlight shows why value‑oriented investors favor steady cash flow, low debt, and strong eye‑care fundamentals.

SEC Form 4 reveals ELEVANCE HEALTH’s share gift to a trust, reducing owner influence while keeping board continuity—and highlights ELEV‑01’s promising 42% response rate.

BDX’s CEO Thomas Polen’s new stock purchases, sales, and SAR vesting reveal a deeper executive stake in Becton, Dickinson’s future.

Boston Scientific stock shows a bullish “hockey‑stick” rebound after a 2026 guidance cut—strong Q2 earnings, insider buying and a growing MiRus program hint at upside potential.

AN2 Therapeutics’ insider gift to a trust signals possible restructuring and future funding plans, while Ashok Leyland’s 12 % revenue jump and premium‑EV push reveal a strategic pivot toward higher‑margin, sustainable commercial vehicles.

Abbott Laboratories’ latest Form 4 shows Executive VP Louis H. Morrone boosting his stake, highlighting insider confidence and the firm’s commitment to transparent governance.